Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $187,994 | 112 | 66.6% |
| Food and Beverage | $43,771 | 1,568 | 15.5% |
| Travel and Lodging | $28,147 | 85 | 10.0% |
| Consulting Fee | $17,578 | 8 | 6.2% |
| Unspecified | $2,779 | 3 | 1.0% |
| Education | $940.21 | 38 | 0.3% |
| Honoraria | $860.08 | 5 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $161,447 | 328 | $0 (2024) |
| Incyte Corporation | $39,393 | 72 | $0 (2024) |
| Galderma Laboratories, L.P. | $35,326 | 135 | $0 (2024) |
| ABBVIE INC. | $7,307 | 260 | $0 (2024) |
| Promius Pharma LLC | $6,113 | 25 | $0 (2018) |
| UCB, Inc. | $4,537 | 65 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $3,445 | 91 | $0 (2024) |
| Almirall LLC | $3,325 | 25 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,997 | 84 | $0 (2024) |
| Janssen Biotech, Inc. | $1,837 | 82 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,520 | 286 | Galderma Laboratories, L.P. ($16,437) |
| 2023 | $45,521 | 283 | Lilly USA, LLC ($20,817) |
| 2022 | $34,232 | 222 | Lilly USA, LLC ($17,799) |
| 2021 | $29,465 | 203 | Lilly USA, LLC ($22,807) |
| 2020 | $35,911 | 169 | Galderma Laboratories, L.P. ($17,618) |
| 2019 | $81,381 | 328 | Lilly USA, LLC ($77,063) |
| 2018 | $9,996 | 184 | Promius Pharma LLC ($5,453) |
| 2017 | $5,044 | 144 | Promius Pharma LLC ($659.52) |
All Payment Transactions
1,819 individual payment records from CMS Open Payments — Page 1 of 73
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $1.79 | General |
| 12/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $3.79 | General |
| 12/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.86 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.01 | General |
| 12/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $1,356.40 | General |
| 12/03/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $951.40 | General |
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.52 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.63 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $9.01 | General |
| 11/22/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $779.38 | General |
| 11/22/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $142.97 | General |
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Immunology | ||||||
| 11/19/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $93.35 | General |
| Category: Inflammation & Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) | Almirall LLC | $2,779 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 4,583 | 8,718 | $992,419 | $453,463 |
| 2022 | 27 | 3,715 | 6,923 | $722,237 | $399,082 |
| 2021 | 26 | 3,559 | 6,387 | $690,205 | $381,441 |
| 2020 | 24 | 3,283 | 5,608 | $529,518 | $282,712 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,335 | 2,539 | $476,994 | $224,983 | 47.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 812 | 1,187 | $118,312 | $47,709 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 349 | 349 | $85,651 | $40,237 | 47.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 350 | 404 | $61,268 | $27,302 | 44.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 80 | 96 | $43,576 | $17,986 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 250 | $33,591 | $16,979 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 267 | 333 | $27,705 | $13,267 | 47.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 546 | 2,683 | $26,740 | $12,551 | 46.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 120 | 143 | $24,157 | $10,884 | 45.1% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 21 | 25 | $11,678 | $6,082 | 52.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 30 | 39 | $9,804 | $4,820 | 49.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 97 | 97 | $10,380 | $4,773 | 46.0% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Office | 2023 | 13 | 13 | $8,709 | $4,552 | 52.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 40 | 41 | $7,728 | $3,792 | 49.1% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 13 | 14 | $6,601 | $3,030 | 45.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $5,343 | $2,648 | 49.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 54 | 68 | $5,115 | $2,560 | 50.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 25 | 27 | $5,008 | $2,357 | 47.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 29 | 46 | $3,906 | $1,545 | 39.6% |
| 11601 | Removal of cancer skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 19 | 19 | $6,333 | $1,491 | 23.5% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 13 | $5,391 | $1,316 | 24.4% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 13 | $4,677 | $1,133 | 24.2% |
| 69100 | Biopsy of ear | Office | 2023 | 17 | 17 | $2,452 | $1,055 | 43.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 48 | 230 | $690.08 | $180.38 | 26.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 18 | $374.24 | $132.48 | 35.4% |
About Dr. Jonathan Schreiber, MD
Dr. Jonathan Schreiber, MD is a Dermatology healthcare provider based in Norfolk, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689785578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Schreiber, MD has received a total of $282,069 in payments from pharmaceutical and medical device companies, with $40,520 received in 2024. These payments were reported across 1,819 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($187,994).
As a Medicare-enrolled provider, Schreiber has provided services to 15,140 Medicare beneficiaries, totaling 27,636 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Norfolk, VA
- Active Since 08/31/2006
- Last Updated 02/26/2015
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1689785578
Products in Payments
- TALTZ (Drug) $140,076
- OPZELURA (Drug) $39,393
- AKLIEF (Drug) $10,362
- Sernivo Spray 120ml (Drug) $5,279
- DUPIXENT (Biological) $4,143
- ORACEA (Drug) $3,997
- Seysara (Drug) $3,184
- EPIDUO FORTE (Drug) $2,638
- SKYRIZI (Biological) $2,413
- RINVOQ (Biological) $1,856
- TREMFYA (Drug) $1,832
- SOOLANTRA (Drug) $1,743
- Humira (Biological) $1,740
- COSENTYX (Biological) $1,240
- Cimzia (Drug) $1,151
- EUCRISA (Drug) $923.04
- ADBRY (Biological) $911.60
- ILUMYA (Biological) $813.12
- Enbrel (Biological) $812.04
- ENSTILAR (Drug) $811.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Norfolk
David Pariser, M.d, M.D
Dermatology — Payments: $752,333
Abby Van Voorhees, Md, MD
Dermatology — Payments: $94,620
Dr. Brian Johnson, Md, MD
Dermatology — Payments: $17,105
James Bota, Md, MD
Dermatology — Payments: $9,662
Katherine Belote, M.d, M.D
Dermatology — Payments: $5,895
Brian Johnson, Md, MD
Dermatology — Payments: $3,734